Replies to post #136023 on BioAmber Inc fka BIOAQ

[trader59]

Put down the bourbon….
Naxos Capital Partners didn’t own BioAmber. That little snippet came from a presentation PowerPoint by an uninvolved company and has been discredited over and over.
You really think all that third party crap somehow are the “facts” and the court records are false?
The DD Fabrication crew lied to you for the sole purpose of flipping the stock for a profit. It’s the sort of con artistry that happens every day on the OTC and it happened here.

[Real McCoy]

Just junk. If the company was bought you wouldn’t have your shares and certainly you and rest of the investing public would be informed of exactly the terms.

[toncatmad]

All that garbage means nothing. This is the last ever 8k from BioAmber and it explains it all quite well. See how they describe certain assets in the very next line as “all the assets”. Goes on to state there is no value for equity investors (shareholders). That was the only transaction. To think otherwise is nuts.
On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment. The purchaser did not seek the assignment of the Company’s contracts, which meant that certain intellectual property under license from third parties was also not transferred to the purchaser.
This transaction was approved by the Quebec Superior Court of Justice on September 18, 2018, and by the United States Bankruptcy Court for the District of Delaware on October 9, 2018.
The liquidation of the Company’s assets will result in little to no residual value for non-secured creditors, and no residual value for equity investors of the Company.

[New money98]

All of the CERTAIN assets sold during the CCAA Liquidation PROCESS!!!